Breathe Technologies Gets FDA Clearance for Home Ventilator

Breathe Technologies Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease (COPD), announced it has received FDA clearance for use of the Breathe Technologies BT-V2S ventilator in the home setting. The one-pound portable device provides ventilation assistance to aid select adult patients who suffer from respiratory insufficiency.

The FDA clearance comes as Breathe prepares for market launch. The company will transfer its operations this year to a new facility in Southern California, where a number of major respiratory and sleep apnea device manufacturers are based. Additionally, industry veteran Rebecca Mabry has joined the Breathe Technologies management team as senior vice president of sales and marketing. Most recently, Mabry was general manager at Midmark Diagnostics Group, a manufacturer of cardiopulmonary diagnostic devices. Prior to that, she served as division president for Sseep diagnostics and therapy at VIASYS / Cardinal Health. During her career, she has held marketing positions with leading respiratory companies such as Bird Products, Healthdyne Technologies, Respironics and SensorMedics.

About The Author